SEARCH LISTED COMPANY
ANY AUS OR NZ COMPANY
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
| FROM | TO | |
|---|---|---|
| ANTEOTECH LTD | 15/11/2019 | |
| ANTEO DIAGNOSTICS LIMITED | 25/11/2008 | 15/11/2019 |
| BIOLAYER CORPORATION LIMITED | 23/01/2006 | 25/11/2008 |
| S.S.H. MEDICAL LIMITED | 23/01/2006 |
Level 8, 210 George Street, Sydney NSW 2000 GPO Box 3993 Sydney NSW 2001
Tel : 1300 737 760 (in Australia) +61 2 9290 9600 (International)name changed to AnteoTech Ltd | 15/11/2019 |
The suspension of trading in the securities of Anteo Diagnostics Limited will be lifted prior to the commencement of trading on Monday, 9 October 2017 following lodgement of the Company's Annual Report for the full year ended 30 June 2017. | 06/10/2017 |
The company lodges its Annual Report to shareholders 30 June 2017. | 06/10/2017 |
The company releases its Corporate Governance Statement. | 06/10/2017 |
The company releases an Appendix 4G. | 06/10/2017 |
The securities of the company will be suspended from official quotation from the commencement of trading today, 2 October 2017, following failure to lodge its full year accounts for the period ended 30 June 2017 in accordance with ASX listing rules. | 02/10/2017 |
The suspension of trading in the securities of Anteo Diagnostics Limited (the "Company") will be lifted immediately, following receipt of an announcement regarding revised terms in relation to the acquisition of DIAsource ImmunoAssays S.A by the Company. Security Code: ADO | 06/01/2016 |
Anteo Diagnostics Limited has agreed revised terms to acquire 100% of the equity in global specialty diagnostics company, DIAsource ImmunoAssays S.A. (Belgium), in line with previously announced acquisition. The originally announced Purchase Price of €15.4m (A$23.7m), with a two year earn out to vendors, subject to achievement of financial business targets (up to a maximum of €7.3m) remains the same. The Purchase Price consideration (€15.4m) is now to be paid 50% in cash up-front (€7.7m) and the balance (€7.7m) to be paid via a deferred payment plan. | 06/01/2016 |
The securities of Anteo Diagnostics Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement in relation to the proposed revision of terms of the proposed DIAsource acquisition. Security Code: ADO | 05/01/2016 |
name changed from Biolayer Corporation Limited | 25/11/2008 |
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 20/11/2018 | Jack Hamilton | 1,000,000 | $0.015 | $15,000.00 |
| 30/04/2018 | Jack Hamilton | 1,050,000 | $0.014 | $14,700.00 |
| 09/11/2017 | John Hurrell | 500,000 | $0.018 | $9,000.00 |
| 28/03/2014 | Geoffrey Cumming | -4,000,000 | $0.258 | $1,031,599.00 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Jack Hamilton | Non Exec Chairman | 01/04/2018 |
| Derek Thomson | CEO | 26/08/2019 |
| Tamara Mills | COO | 15/08/2016 |
| Duncan Cornish | CFO, Company Secretary | 28/02/2019 |
| Geoffrey Cumming | Non Exec Director | 02/04/2009 |
| Richard Martin | Director | 23/09/2005 |
| Matthew Sanderson | Director | 19/10/2017 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|
Date of first appointment, title may have changed.
